2020’s Market Was More Complex Than It Will Appear

MarketFoolery - A podcast by The Motley Fool

Podcast artwork

AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.

Visit the podcast's native language site